Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Causal attribution fractions, and the attribution of smoking and BMI to the landscape of disease incidence in UK Biobank

View through CrossRef
Unlike conventional epidemiological studies that use observational data to estimate “associations” between risk factors and disease, the science of causal inference has identified situations where causal estimates can be made from observational data, using results such as the “backdoor criteria”. These results are combined here with established epidemiological methods, to calculate simple population attribution fractions that estimate the causal influence of risk factors on disease incidence, and can be estimated using conventional proportional hazards methods. A counterfactual argument gives an attribution fraction for individuals. Causally meaningful attribution fractions cannot be constructed for all risk factors or confounders, but they can for the important established risk factors of smoking and body mass index (BMI). Using the new results, the causal attribution of smoking and BMI to the incidence of 226 diseases in the UK Biobank are estimated, and summarised in terms of disease chapters from the International Classification of Diseases (ICD-10). The diseases most strongly attributed to smoking and BMI are identified, finding 11 with attribution fractions greater than 0.5, and a small number with protective associations. The results provide new tools to quantify the causal influence of risk factors such as smoking and BMI on disease, and survey the causal influence of smoking and BMI on the landscape of disease incidence in the UK Biobank population.
Title: Causal attribution fractions, and the attribution of smoking and BMI to the landscape of disease incidence in UK Biobank
Description:
Unlike conventional epidemiological studies that use observational data to estimate “associations” between risk factors and disease, the science of causal inference has identified situations where causal estimates can be made from observational data, using results such as the “backdoor criteria”.
These results are combined here with established epidemiological methods, to calculate simple population attribution fractions that estimate the causal influence of risk factors on disease incidence, and can be estimated using conventional proportional hazards methods.
A counterfactual argument gives an attribution fraction for individuals.
Causally meaningful attribution fractions cannot be constructed for all risk factors or confounders, but they can for the important established risk factors of smoking and body mass index (BMI).
Using the new results, the causal attribution of smoking and BMI to the incidence of 226 diseases in the UK Biobank are estimated, and summarised in terms of disease chapters from the International Classification of Diseases (ICD-10).
The diseases most strongly attributed to smoking and BMI are identified, finding 11 with attribution fractions greater than 0.
5, and a small number with protective associations.
The results provide new tools to quantify the causal influence of risk factors such as smoking and BMI on disease, and survey the causal influence of smoking and BMI on the landscape of disease incidence in the UK Biobank population.

Related Results

Threshold effect and sex characteristics of the relationship between chronic inflammation and BMI
Threshold effect and sex characteristics of the relationship between chronic inflammation and BMI
AbstractChronic inflammation is an important pathway for obesity to harm health, the aggravation of chronic inflammation occurs without clinical symptoms. BMI is closely related to...
Causal discovery and prediction: methods and algorithms
Causal discovery and prediction: methods and algorithms
(English) This thesis focuses on the discovery of causal relations and on the prediction of causal effects. Regarding causal discovery, this thesis introduces a novel and generic m...
Cohort profile: A Québec-based plasma donor biobank to study COVID-19 immunity (PlasCoV)
Cohort profile: A Québec-based plasma donor biobank to study COVID-19 immunity (PlasCoV)
AbstractPurposeLong-term humoral immunity to COVID-19 is not well understood owing to the continuous emergence of new variants of concern, the evolving vaccine- and infection-induc...
Ubap2l-Bmi-1-Rnf2 Define a Novel Polycomb Complex Essential For Self-Renewal Of Hematopoietic Stem Cells
Ubap2l-Bmi-1-Rnf2 Define a Novel Polycomb Complex Essential For Self-Renewal Of Hematopoietic Stem Cells
Abstract The polycomb group protein Bmi-1 is a well known determinant of hematopoietic stem cell function. Bmi-1-/- mice display severe hematopoietic defects, includ...
Psychobiological Theories of Smoking and Smoking Motivation
Psychobiological Theories of Smoking and Smoking Motivation
Abstract. Theories of smoking have been developed about the conditions and causes of smoking as well as for explaining its maintenance. Moreover, factors of smoking motivation have...
Health Promotion Model Not Smoking among Adolescents: A Path Analysis Evidence from Indonesia
Health Promotion Model Not Smoking among Adolescents: A Path Analysis Evidence from Indonesia
<p>Smoking behavior is a threat to public health. This study identified factors that influence non-smoking behavior among adolescents. The aim is to determine the effect of m...
Nursing Assistance To The Patient With Acute Myocardial Infarction; Nursing Implications
Nursing Assistance To The Patient With Acute Myocardial Infarction; Nursing Implications
In this treatise we intend to deepen the theme of Acute Myocardial Infarction (AMI), one of its main risk factors at the cardiovascular level, namely smoking, and in particular, de...
Varenicline Versus Cytisine for Smoking Cessation in a Primary Care Setting: A Randomized Controlled Trial
Varenicline Versus Cytisine for Smoking Cessation in a Primary Care Setting: A Randomized Controlled Trial
Abstract Our study aims to implement a smoking cessation program using pharmacotherapy in a real-life setting — primary care practices in Croatia and Slovenia — and...

Back to Top